Cargando…

Contribution of adverse events to death of hospitalised patients

BACKGROUND: There is no standardised method to investigate death as a patient safety indicator and we need valid and reliable measurements to use adverse events contributing to death as a quality measure. OBJECTIVE: To investigate the contribution of severe adverse events to death in hospitalised pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haukland, Ellinor Christin, Mevik, Kjersti, von Plessen, Christian, Nieder, Carsten, Vonen, Barthold
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6440591/ https://www.ncbi.nlm.nih.gov/pubmed/30997413 http://dx.doi.org/10.1136/bmjoq-2018-000377

Ejemplares similares

Adverse events in deceased hospitalised cancer patients as a measure of quality and safety in end-of-life cancer care
por: Haukland, Ellinor Christin, et al.
Publicado: (2020)

Does increasing the size of bi-weekly samples of records influence results when using the Global Trigger Tool? An observational study of retrospective record reviews of two different sample sizes
por: Mevik, Kjersti, et al.
Publicado: (2016)

Days at home in the last three months of life: patterns-of-care analysis in patients with non-small cell lung cancer
por: Nieder, Carsten, et al.
Publicado: (2023)

Early death after palliative radiation treatment: 30-, 35- and 40-day mortality data and statistically robust predictors
por: Nieder, Carsten, et al.
Publicado: (2023)

The LabBM score is an excellent survival prediction tool in patients undergoing palliative radiotherapy
por: Nieder, Carsten, et al.
Publicado: (2021)

Exceptional Responses to Standard Therapy in a Patient with Metastatic HER2-Positive Breast Cancer
por: Nieder, Carsten, et al.
Publicado: (2017)

30-day mortality in patients treated for brain metastases: extracranial causes dominate
por: Nieder, Carsten, et al.
Publicado: (2022)

Primary systemic therapy for patients with brain metastases from lung cancer ineligible for targeted agents
por: Nieder, Carsten, et al.
Publicado: (2022)

Leptomeningeal carcinomatosis from renal cell cancer: treatment attempt with radiation and sunitinib (case report)
por: Dalhaug, Astrid, et al.
Publicado: (2010)

Is there a seasonal variation of survival after systemic chemotherapy for metastatic castration-resistant prostate cancer in a rural part of North Norway?
por: Nieder, Carsten, et al.
Publicado: (2020)

Palliative Thoracic Radiotherapy for Non-Small Cell Lung Cancer in Outpatients: Reasons for Unplanned Hospitalization and Its Impact on Survival
por: Nieder, Carsten, et al.
Publicado: (2021)

Anaemia and thrombocytopenia in patients with prostate cancer and bone metastases
por: Nieder, Carsten, et al.
Publicado: (2010)

Pathologic fracture and metastatic spinal cord compression in patients with prostate cancer and bone metastases
por: Nieder, Carsten, et al.
Publicado: (2010)

Palliative non-small cell lung cancer treatment and end-of-life care stratified by sex and childlessness: an important interplay in unmarried patients?
por: Nieder, Carsten, et al.
Publicado: (2022)

Shortened Palliative Radiotherapy Results in a Lower Rate of Treatment During the Last Month of Life
por: Nieder, Carsten, et al.
Publicado: (2022)

Management of patients with metastatic prostate cancer (mPC) in a rural part of North Norway with a scattered population: does living near the department of oncology translate into a different pattern of care and survival?
por: Nieder, Carsten, et al.
Publicado: (2019)

Does Time between Imaging Diagnosis and Initiation of Radiotherapy Impact Survival after Whole-Brain Radiotherapy for Brain Metastases?
por: Nieder, Carsten, et al.
Publicado: (2013)

Survival Prediction Score: A Simple but Age-Dependent Method Predicting Prognosis in Patients Undergoing Palliative Radiotherapy
por: Angelo, Kent, et al.
Publicado: (2014)

Prognostic Impact of the Tumor Marker CA 15-3 in Patients With Breast Cancer and Bone Metastases Treated With Palliative Radiotherapy
por: Nieder, Carsten, et al.
Publicado: (2017)

Palliative appropriateness criteria: external validation of a new method to evaluate the suitability of palliative radiotherapy fractionation
por: Nieder, Carsten, et al.
Publicado: (2023)

Contemporary radiooncological management of bone metastases from breast cancer: factors associated with prescription of different fractionation regimens (short or long course) in a rural part of North Norway with long travel distance
por: Nieder, Carsten, et al.
Publicado: (2017)

The Glasgow prognostic score: Useful information when prescribing palliative radiotherapy
por: Nieder, Carsten, et al.
Publicado: (2017)

Risk factors for esophagitis after hypofractionated palliative (chemo) radiotherapy for non-small cell lung cancer
por: Nieder, Carsten, et al.
Publicado: (2020)

Palliative radiotherapy with or without additional care by a multidisciplinary palliative care team in patients with newly diagnosed cancer: a retrospective matched pairs comparison
por: Nieder, Carsten, et al.
Publicado: (2015)

Development of a Score Predicting Survival after Palliative Reirradiation
por: Nieder, Carsten, et al.
Publicado: (2014)

Presence of Brain Metastases at Initial Diagnosis of Cancer: Patient Characteristics and Outcome
por: Nieder, Carsten, et al.
Publicado: (2019)

Oligometastatic Non-Small Cell Lung Cancer: A Significant Entity outside of Specialized Cancer Centers?
por: Nieder, Carsten, et al.
Publicado: (2014)

Palliative Radiotherapy with or without Additional Care by a Multidisciplinary Palliative Care Team: A Retrospective Comparison
por: Nieder, Carsten, et al.
Publicado: (2014)

Should the surgeon or the general practitioner (GP) follow up patients after surgery for colon cancer? A randomized controlled trial protocol focusing on quality of life, cost-effectiveness and serious clinical events
por: Augestad, Knut M, et al.
Publicado: (2008)

Contributions of event rates, pre-hospital deaths, and deaths following hospitalisation to variations in myocardial infarction mortality in 326 districts in England: a spatial analysis of linked hospitalisation and mortality data
por: Asaria, Perviz, et al.
Publicado: (2022)

An electronic trigger based on care escalation to identify preventable adverse events in hospitalised patients
por: Bhise, Viraj, et al.
Publicado: (2018)

Development of a Clinical Prediction Rule for Adverse Events in Multimorbid Patients in Emergency and Hospitalisation
por: Morales-Puerto, Marta, et al.
Publicado: (2022)

The One-stop trial: Does electronic referral and booking by the general practitioner (GPs) to outpatient day case surgery reduce waiting time and costs? A randomized controlled trial protocol
por: Augestad, Knut Magne, et al.
Publicado: (2008)

Anal incontinence, urinary incontinence and sexual problems in primiparous women – a comparison between women with episiotomy only and women with episiotomy and obstetric anal sphincter injury
por: Stedenfeldt, Mona, et al.
Publicado: (2014)

Hospital deaths and adverse events in Brazil
por: Martins, Mônica, et al.
Publicado: (2011)

Adverse events and in-hospital mortality: an analysis of all deaths in a Norwegian health trust during 2011
por: Flaatten, Hans, et al.
Publicado: (2017)

Quality of obstetric care in the sparsely populated sub-arctic area of Norway 2009–2011
por: Norum, Jan, et al.
Publicado: (2013)

Nature of adverse events with opioids in hospitalised patients: a post-hoc analysis of three patient record review studies
por: Schutijser, Bernadette Clara Francisca Maria, et al.
Publicado: (2020)

Risk factors for death in patients with non-infectious adverse events
por: Gadelha, Gilcilene Oliveira, et al.
Publicado: (2018)

Prioritisation of Adverse Drug Events Leading to Hospital Admission and Occurring during Hospitalisation: A RAND Survey
por: Haerdtlein, Annette, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_23gt4ap3ierdcp2bjmvn3smbm2